Feed SONVF
SO

Sonova Holding AG

SONVF · OTC

$280.00 +3.53% (+$9.54)
1M -5.80%
Market Cap CHF 13.7B
P/E Ratio 25.31x
Div. Yield 1.35%
ROE 21.63%

Bulios Fair Price

$198.27

29.2% downside

Current Price

$280

Undervalued Fair Value Overvalued

According to Bulios Fair Price, SONVF is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
7/9
Valuation
49 /100
Fair
P/B 5.13x
P/S 3.54x
P/E 25.31x
Growth
22 /100
Declining
Book val. growth 3.40%
FCF growth 7.01%
EPS growth 4.41%
Profitability
88 /100
Strong
FCF margin 16.97%
Op. margin 17.90%
Gross margin 72.04%
Quality
76 /100
Excellent
Asset turnover 0.65x
ROA 9.12%
ROIC 11.95%
Debt
79 /100
Low
Net debt/EBITDA 1.16x
Int. coverage 25.60x
Debt/Equity 0.66x
Stability
94 /100
Stable
Profitable years 6
EPS volatility 6.96%
Beta 1.11x

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about SONVF
Online

About the company

Sonova Holding AG is a Swiss multinational company headquartered in Stäfa, founded in 1947. The company specializes in the development, manufacture, and sale of hearing aids and other solutions for people with hearing impairments. Its well-known brands include Phonak, Unitron, and Hansaton. Sonova provides products and services that improve the quality of life for people with hearing loss, including hearing aids as well as communication enhancement solutions such as implants and accessories. The company operates globally and has branches in over 100 countries.

Sector

Healthcare

Industry

Medical - Devices

CEO

Eric Alain Bernard

Employees

18,447

Headquarters

Stäfa

Upcoming events

12 NOV

Earnings

Upcoming earnings report

52d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.